Literature DB >> 2602532

Alexithymic characteristics in rheumatoid arthritis: a controlled study.

A Fernandez1, T G Sriram, S Rajkumar, A N Chandrasekar.   

Abstract

Forty rheumatoid arthritis (RA) patients diagnosed by rigid criteria were evaluated for alexithymic characteristics using the Beth Israel Hospital Psychosomatic Questionnaire (BIQ) and the Toronto Alexithymia Scale (TAS). 40 healthy subjects matched with RA patients on sociodemographic variables served as controls. RA patients scored significantly higher on the BIQ and TAS compared to controls. The two scales correlated in the expected direction. Using the TAS cutoff score of 74 and above, 11 RA patients (27.5%) were identified as alexithymic. RA patients with greater functional impairment showed significantly higher alexithymia scores.

Entities:  

Mesh:

Year:  1989        PMID: 2602532     DOI: 10.1159/000288133

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  4 in total

1.  Depression partially mediates the relationship between alexithymia and somatization in a sample of healthy children.

Authors:  Laura B Allen; Jennie C I Tsao; Loran P Hayes; Lonnie K Zeltzer
Journal:  J Health Psychol       Date:  2011-04-04

2.  Psychologic interventions and lifestyle modifications for arthritis pain management.

Authors:  Francis J Keefe; Tamara J Somers; Lynn M Martire
Journal:  Rheum Dis Clin North Am       Date:  2008-05       Impact factor: 2.670

3.  Alexithymia in individuals with chronic pain and its relation to pain intensity, physical interference, depression, and anxiety: a systematic review and meta-analysis.

Authors:  Rachel V Aaron; Emma A Fisher; Rocio de la Vega; Mark A Lumley; Tonya M Palermo
Journal:  Pain       Date:  2019-05       Impact factor: 7.926

4.  Alexithymic Traits and Hair Cortisol Concentrations in Pregnant Women.

Authors:  Jani Kajanoja; Max Karukivi; Paula Mustonen; Noora M Scheinin; Susanna Kortesluoma; Ana João Rodrigues; Hasse Karlsson; Linnea Karlsson
Journal:  Front Psychiatry       Date:  2020-05-13       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.